Estrogen alters baseline and inflammatory-induced cytokine levels independent from hypothalamic-pituitary-adrenal axis activity

Cytokine

Volumn 72, Issue 2, 2015, Pages 121-129

  Shivers, Kai Yvonne ^a   Amador, Nicole ^a   Abrams, Lisa ^a,b   Hunter, Deirtra ^a,c   Jenab, Shirzad ^a   Quiñones Jenab, Vanya ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b ROWAN UNIVERSITY   (United States)

^c MARYMOUNT MANHATTAN COLLEGE   (United States)

Author keywords

Adrenalectomy; Cytokines; Estrogen; Inflammation; Ovariectomy

Indexed keywords

CHOLESTEROL; CYTOKINE; ESTRADIOL; ESTROGEN; FORMALDEHYDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FOOT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; NONHUMAN; OVARIECTOMY; RAT; SERUM; SPINAL CORD; SPINAL GANGLION; ANIMAL; BLOOD; DEFICIENCY; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; METABOLISM; PAIN; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ADRENALECTOMY; ANIMALS; CYTOKINES; ESTRADIOL; ESTROGENS; FORMALDEHYDE; GANGLIA, SPINAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; OVARIECTOMY; PAIN; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922183230     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.01.007     Document Type: Article

References (69)

1. Christenson E.S., Jiang X., Kagan R., Schnatz P. Osteoporosis management in post-menopausal women. Minerva Ginecol 2012, 64:181-194.
2. Chae C.U., Derby C.A. The menopausal transition and cardiovascular risk. Obstet Gynecol Clin North Am 2011, 38:477-488.
3. Roman-Blas J.A., Castaneda S., Largo R., Herrero-Beaumont G. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther 2009, 11:241.
4. Barron A.M., Pike C.J. Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) 2012, 4:976-997.
5. Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm 2013, 2013:480739.
6. Uceyler N., Schafers M., Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res 2009, 196:67-78.
7. Zelenka M., Schafers M., Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005, 116:257-263.
8. Siegel J.P., Puri R.K. Interleukin-2 toxicity. J Clin Oncol 1991, 9:694-704.
9. Yan J., Melemedjian O.K., Price T.J., Dussor G. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain 2012, 8:6.
10. Schafers M., Svensson C.I., Sommer C., Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003, 23:2517-2521.
11. Zhang L., Berta T., Xu Z.Z., Liu T., Park J.Y., Ji R.R. TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain 2011, 152:419-427.
12. Honore P., Wade C.L., Zhong C., Harris R.R., Wu C., Ghayur T., et al. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res 2006, 167:355-364.
13. Svensson C.I., Schafers M., Jones T.L., Powell H., Sorkin L.S. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 2005, 379:209-213.
14. Zhang H., Zhang H., Dougherty P.M. Dynamic effects of TNF-alpha on synaptic transmission in mice over time following sciatic nerve chronic constriction injury. J Neurophysiol 2013, 110:1663-1671.
15. Hashizume H., DeLeo J.A., Colburn R.W., Weinstein J.N. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 2000, 25:1206-1217. [Phila Pa 1976].
16. Raghavendra V., Tanga F., Rutkowski M.D., DeLeo J.A. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 2003, 104:655-664.
17. Schoeniger-Skinner D.K., Ledeboer A., Frank M.G., Milligan E.D., Poole S., Martin D., et al. Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 2007, 21:660-667.
18. Milligan E.D., Sloane E.M., Langer S.J., Hughes T.S., Jekich B.M., Frank M.G., et al. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 2006, 126:294-308.
19. Ledeboer A., Jekich B.M., Sloane E.M., Mahoney J.H., Langer S.J., Milligan E.D., et al. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 2007, 21:686-698.
20. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999, 16:851-863.
21. Hunter D.A., Barr G.A., Amador N., Shivers K.Y., Kemen L., Kreiter C.M., et al. Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation. Synapse 2011, 65:643-651.
22. Kuba T., Kemen L.M., Quinones-Jenab V. Estradiol administration mediates the inflammatory response to formalin in female rats. Brain Res 2005, 1047:119-122.
23. Mannino C.A., South S.M., Quinones-Jenab V., Inturrisi C.E. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test. J Pain 2007, 8:334-342.
24. Sarajari S., Oblinger M.M. Estrogen effects on pain sensitivity and neuropeptide expression in rat sensory neurons. Exp Neurol 2010, 224:163-169.
25. Okuda K., Iwasaka H., Hagiwara S., Takeshima N., Takatani J., Uchino T., et al. The antinociceptive effects of estradiol on adjuvant-induced hyperalgesia in rats involve activation of adrenergic and serotonergic systems. J Anesth 2011, 25:392-397.
26. Cuzzocrea S., Santagati S., Sautebin L., Mazzon E., Calabro G., Serraino I., et al. 17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology 2000, 141:1455-1463.
27. Esposito E., Iacono A., Raso G.M., Pacilio M., Coppola A., Di C.R., et al. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 2005, 146:3301-3308.
28. Smith J.A., Das A., Butler J.T., Ray S.K., Banik N.L. Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem Res 2011, 36:1587-1593.
29. Liu H., Liu K., Bodenner D.L. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation. Cytokine 2005, 31:251-257.
30. Masiukiewicz U.S., Mitnick M., Grey A.B., Insogna K.L. Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro. Endocrinology 2000, 141:2526-2531.
31. Subramanian S., Tovey M., Afentoulis M., Krogstad A., Vandenbark A.A., Offner H. Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol 2005, 115:162-172.
32. Lewis D.K., Johnson A.B., Stohlgren S., Harms A., Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J Neuroimmunol 2008, 195:47-59.
33. Ritz M.F., Hausmann O.N. Effect of 17β-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res 2008, 1203:177-188.
34. Chen B.L., Li Y.Q., Xie D.H., He Q.L., Yang X.X. Blocking TNF-alpha with infliximab alleviates ovariectomy induced mechanical and thermal hyperalgesia in rats. Neurol Sci 2012, 33:527-533.
35. DeRijk R., Michelson D., Karp B., Petrides J., Galliven E., Deuster P., et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 1997, 82:2182-2191.
36. Sternberg E.M. Neural-immune interactions in health and disease. J Clin Invest 1997, 100:2641-2647.
37. Kirwan J.R., Buttgereit F. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis. Rheumatology 2012, 51(Suppl 4):iv14-iv20. [Oxford].
38. Chensue S.W., Terebuh P.D., Remick D.G., Scales W.E., Kunkel S.L. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991, 138:395-402.
39. Kapcala L.P., Chautard T., Eskay R.L. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress. Ann N Y Acad Sci 1995, 771:419-437.
40. Blandino P., Barnum C.J., Solomon L.G., Larish Y., Lankow B.S., Deak T. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun 2009, 23:958-968.
41. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., Lightman S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J Neuroendocrinol 2004, 16:989-998.
42. Niyomchai T., Russo S.J., Festa E.D., Akhavan A., Jenab S., Quinones-Jenab V. Progesterone inhibits behavioral responses and estrogen increases corticosterone levels after acute cocaine administration. Pharmacol Biochem Behav 2005, 80:603-610.
43. Ferrini M., Gonzalez S., Nicola A.F. Estradiol increases glucocorticoid binding and glucocorticoid induction of ornithine decarboxylase in the rat spinal cord. Life Sci 1993, 52:677-685.
44. Liu J., Bisschop P.H., Eggels L., Foppen E., Fliers E., Zhou J.N., et al. Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats. Endocrinology 2012, 153:3337-3344.
45. Kuba T., Hunter D., Zhou L., Jenab S., Quinones-Jenab V. Acute and chronic estradiol replacements differentially alter corticosterone and COX-mediated responses to an inflammatory stimulus in female rats. Ethn Dis 2010, 20:S1-S4.
46. Hulse R.E., Kunkler P.E., Fedynyshyn J.P., Kraig R.P. Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods 2004, 136:87-98.
47. Samantaray S., Smith J.A., Das A., Matzelle D.D., Varma A.K., Ray S.K., et al. Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res 2011, 36:1809-1816.
48. Kuba T., Wu H.B., Nazarian A., Festa E.D., Barr G.A., Jenab S., et al. Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats. Horm Behav 2006, 49:441-449.
49. Torres-Chavez K.E., Sanfins J.M., Clemente-Napimoga J.T., Pelegrini-Da-Silva A., Parada C.A., Fischer L., et al. Effect of gonadal steroid hormones on formalin-induced temporomandibular joint inflammation. Eur J Pain 2012, 16:204-216.
50. Hunter D.A., Barr G.A., Shivers K.Y., Amador N., Jenab S., Inturrisi C., et al. Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia. Brain Res 2011, 1382:181-188.
51. Sommer C., Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004, 361:184-187.
52. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664.
53. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698-700.
54. Sorkin L.S., Xiao W.H., Wagner R., Myers R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997, 81:255-262.
55. Moalem G., Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006, 51:240-264.
56. Rittner H.L., Machelska H., Stein C. Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 2005, 78:1215-1222.
57. Hoyer K.K., Dooms H., Barron L., Abbas A.K. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008, 226:19-28.
58. Hanisch U.K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev 1995, 21:246-284.
59. Sredni-Kenigsbuch D. TH1/TH2 cytokines in the central nervous system. Int J Neurosci 2002, 112:665-703.
60. Thompson C.D., Zurko J.C., Hanna B.F., Hellenbrand D.J., Hanna A. The therapeutic role of interleukin-10 after spinal cord injury. J Neurotrauma 2013, 30:1311-1324.
61. O'Banion M.K., Winn V.D., Young D.A. CDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992, 89:4888-4892.
62. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002, 20:125-163.
63. Martin-Millan M., Castaneda S. Estrogens, osteoarthritis and inflammation. Joint Bone Spine 2013, 80:368-373.
64. Schaefer T.M., Wright J.A., Pioli P.A., Wira C.R. IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells. J Immunol 2005, 175:6509-6516.
65. Bruce-Keller A.J., Keeling J.L., Keller J.N., Huang F.F., Camondola S., Mattson M.P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000, 141:3646-3656.
66. Lawson K.P., Nag S., Thompson A.D., Mokha S.S. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia. Pain 2010, 151:806-815.
67. Baker A.E., Brautigam V.M., Watters J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004, 145:5021-5032.
68. Nweze I.C., Smith J.W., Zhang B., Klinge C.M., Lakshmanan J., Harbrecht B.G. 17beta-Estradiol attenuates cytokine-induced nitric oxide production in rat hepatocyte. J Trauma Acute Care Surg 2012, 73:408-412.
69. Doucet D., Badami C., Palange D., Bonitz R.P., Lu Q., Xu D.Z., et al. Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats. PLoS ONE 2010, 5:e9421.